ShockWave Medical, Inc.
NASDAQ:SWAV
334.75 (USD) • At close May 30, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 730.23 | 489.733 | 237.146 | 67.789 | 42.927 | 12.263 | 1.719 |
| Kosten van de omzet
| 95.388 | 64.996 | 41.438 | 20.991 | 17.159 | 7.25 | 2.836 |
| Brutowinst
| 634.842 | 424.737 | 195.708 | 46.798 | 25.768 | 5.013 | -1.117 |
| Brutowinstmarge
| 0.869 | 0.867 | 0.825 | 0.69 | 0.6 | 0.409 | -0.65 |
| Onderzoek- en ontwikkelingskosten
| 145.647 | 81.679 | 50.544 | 36.926 | 32.853 | 22.698 | 17.963 |
| Algemene en administratieve kosten
| 95.265 | 56.929 | 34.747 | 23.863 | 14.134 | 5.979 | 5.422 |
| Verkoop- en marketingkosten
| 234.837 | 161.995 | 111.288 | 51.672 | 30.62 | 17.536 | 6.363 |
| Verkoop-, algemene en administratieve kosten
| 323.202 | 218.924 | 146.035 | 75.535 | 44.754 | 23.515 | 11.785 |
| Overige kosten
| 23.962 | 1.055 | -0.582 | 1.256 | 2.345 | 0.589 | 0.366 |
| Bedrijfskosten
| 468.849 | 300.603 | 196.579 | 112.461 | 77.607 | 46.213 | 29.748 |
| Bedrijfsresultaat
| 165.993 | 124.134 | -0.871 | -65.663 | -51.839 | -41.2 | -30.865 |
| Bedrijfsresultaat ratio
| 0.227 | 0.253 | -0.004 | -0.969 | -1.208 | -3.36 | -17.955 |
| Totaal overige inkomsten en kosten netto
| 8.288 | -3.306 | -7.964 | 0.044 | 0.792 | 0.537 | 0.334 |
| Inkomen voor belasting
| 174.281 | 120.828 | -8.835 | -65.619 | -51.047 | -41.064 | -30.589 |
| Inkomen voor belasting ratio
| 0.239 | 0.247 | -0.037 | -0.968 | -1.189 | -3.349 | -17.795 |
| Belastingkosten
| 27.003 | -95.168 | 0.301 | 0.08 | 0.062 | 0.038 | 0.026 |
| Nettowinst
| 147.278 | 215.996 | -9.136 | -65.699 | -51.109 | -41.102 | -30.615 |
| Nettowinstmarge
| 0.202 | 0.441 | -0.039 | -0.969 | -1.191 | -3.352 | -17.81 |
| WPA (Winst Per Aandeel)
| 4.01 | 6.02 | -0.26 | -1.99 | -2.14 | -1.53 | -1.57 |
| Verwaterde WPA
| 3.85 | 5.7 | -0.26 | -1.99 | -2.14 | -1.53 | -1.57 |
| EBITDA
| 176.351 | 122.714 | -7.739 | -64.407 | -49.494 | -39.911 | -30.031 |
| EBITDA ratio
| 0.242 | 0.251 | -0.033 | -0.95 | -1.153 | -3.255 | -17.47 |